Preparation and In-Vitro Evaluation of Sustained-Release Matrix Tablets of Diltiazem
Keywords:
Sustain release, Diltiazem, HPMCAbstract
The purpose of the present research work was develop once-daily sustained-release matrix tablet containing watersoluble drug (Diltiazem) that is a novel calcium channel blocker used in cardiovascular diseases, by utilizing a combination of Hypromellose (HPMC), Eudragit with different grades and finally milled Ethyl cellulose. Tablets were prepared by the wet granulation method. The prepared granules and tablets were evaluated based on a range of parameters and in vitro drug release profile. Lastly, tablets shown approx 92%, 97% and 99 % drug release at the last dosing interval.
References
Frydman MA, Chapelle P. Diekmann H.
“Pharmacokinetics of Diltiazem.” Am J
Cardiol. 1989:20:25-33.
O'Connor SE., Grosset A, Janiak P. “The
pharmacological basis and
pathophysiological significance of the
heart rate-lowering property of Diltiazem.”
Fundamental and Clinical Pharmacology.
:13(2):145-53.
Sajid MS, Rimple J, Cheek E, Baig MK.
“The efficacy of Diltiazem and
glyceryltrinitrate for the medical
management of chronic anal fissure: a
meta-analysis”. Int J Colorectal Disease.
:23(1):1-6.
Nash GF, Kapoor K, Saeb-Parsy K,
Kunanadam T, Dawson PM. The longterm results of Diltiazem treatment for
anal fissure. Int J Cl. Prac.
:60(11):1411-3.
Tripathi KD, Essentials of Medical
Pharmacology 5th edition 2003: Jaypee
brothers medical Publishers. New Delhi
-496.
Lachman L, Liberman HA, Kanig JL, The
Theory and Practice of Industrial
Pharmacy. Mumbai, India: Varghese
Publishing House : 1987:430-456.
Cooper J, Gunn C. Powder flow and
compaction. In: Carter SJ, eds. Tutorial
Pharmacy. New Delhi, India: CBS
Publishers and Distributors: 1986:211-
Lachman L, Lieberman HA, Kanig JL.
Tablets in The theory and practice of
pharmacy Varghese Publishing house
:317-320.
Shah D, Shah Y, Rampradhan M,
Development and evaluation of controlled
release Diltiazem hydrochloride
microparticles using cross-linked
poly(vinyl alcohol). Drug Del Ind Pharm.
:23(6):567-574.
Aulton ME, Wells TI, Pharmaceutics: The
Science of Dosage Form Design. London,
England: Churchill Livingstone : 1988:
-189.
Martin A, Micromeritics. In: Martin A,
eds. Physical Pharmacy. Baltimore, MD:
Lippincott Williams & Wilkins :
:423-454.
Pharmacopoeia of India. New Delhi:
Ministry of Health and Family Welfare,
Government of India, Controller of
Publications : 1996:899-900
Lachman L, Liberman HA, Kanig JL, eds.
The Theory and Practice of Industrial
Pharmacy. Mumbai, India: Varghese
Publishing House : 1987:293-345.
Aulton ME, Wells TI, Pharmaceutics: The
Science of Dosage Form Design. London,
England: Churchill Livingstone :
:182-183
Khemariya P, Bhargava M, Singhai SK,
“Preparation and evaluation of mouth
dissolving tablets of meloxicam” Int J
Drug Del 2010:71-78
Mutalik S, Hiremath D, Formulation and
evaluation of chitosan matrix tablets of
nifedipine. The Eastern Pharmacist.
:2:109-111.
Khan KA, Rhodes CT, Evaluation of
different viscosity grades of sodium
carboxy methylcellulose as tablet
disintegrants. Pharm Acta Helv.
:50:99-102.
Shah NH, Lazarus JH, Jarwoski CL,
Carboxy methylcellulose: Effect of degree
of polymerization and substitution on
tablet disintegration and dissolution. J
Pharm Sci. 1981:70 (6):611-613.
Korsmeyer RW, Gurny R, Peppas NA,
Mechanisms of solute release from porous
hydrophilic polymers. Int J Pharm.
:15:25-35.
Fassihi RA, Ritschel WA, Multiple layer,
direct compression controlled release
system: In vitro and in vivo evaluation. J
Pharm Sci. 1993:82:750-754.
Khemariya P, Mishra S, Shukla A et al An
Emerging Trend In Tablet TechnologyFloating Tablets of Ranitidine HCl: Int. J
Drug Del 2010:2,154-158
